Skip to main navigation Skip to search Skip to main content

The development of N-α-(2-carboxyl)benzoyl- N 5-(2-fluoro- 1-iminoethyl)- l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl) benzoyl-N5-(2-chloro-1-iminoethyl)-l-ornithine amide (o -Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors

  • Corey P. Causey
  • , Justin E. Jones
  • , Jessica L. Slack
  • , Daisuke Kamei
  • , Larry E. Jones
  • , Venkataraman Subramanian
  • , Bryan Knuckley
  • , Pedram Ebrahimi
  • , Alexander A. Chumanevich
  • , Yuan Luo
  • , Hiroshi Hashimoto
  • , Mamoru Sato
  • , Lorne J. Hofseth
  • , Paul R. Thompson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)6919-6935
Number of pages17
JournalJournal of Medicinal Chemistry
Volume54
Issue number19
DOIs
StatePublished - Oct 13 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'The development of N-α-(2-carboxyl)benzoyl- N 5-(2-fluoro- 1-iminoethyl)- l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl) benzoyl-N5-(2-chloro-1-iminoethyl)-l-ornithine amide (o -Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors'. Together they form a unique fingerprint.

Cite this